As we mark the Affordable Care Act’s 5th anniversary, the linked issues of access to health care and to information technology are flash points for debate. On Tuesday, March 24th, at a panel [...]
Most people are familiar with generic drugs – often cheaper copies of brand-name drugs – but biosimilars are a relatively new concept in the U.S., although they’ve existed in Europe for several [...]
